Another CRISPR approval not likely ‘any time soon’ – report (NASDAQ:CRSP)
Bill Oxford/iStock via Getty Images Following the recent FDA green light for the gene therapy Casgevy, "it is unlikely" that approval of a similar product will take place "any time soon," according to a report by GlobalData. According…